Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.

Source:http://linkedlifedata.com/resource/pubmed/id/12411306

Blood 2003 Mar 1 101 5 1905-12

Download in:

View as

General Info

PMID
12411306